Centro de documentación: resultados de la búsqueda

Artículo
Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease
Autor/es:
Hopfner F, Wod M, Höglinger GU, Blaabjerg M, Rösler TW, Kuhlenbäumer G, Christensen K, Deuschl G, Pottegård A.
Año publicación:
2019
Número de revista:
Neurology vol. 93 n. 2
http://n.neurology.org/content/93/2/e135.abstract
Artículo
Neuropathy with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A meta-analysis
Autor/es:
Roy B, Das A, Ashish K, Bandyopadhyay D, Maiti A, Chakraborty S, Stone ME, Philpotts LL, Nowak RJ, Patwa HS.
Año publicación:
2019
Número de revista:
Neurology vol. 93 n. 2
http://n.neurology.org/content/93/2/e143.abstract
Artículo
Natural course of scoliosis and lifetime risk of scoliosis surgery in spinal muscular atrophy
Autor/es:
Wijngaarde CA, Brink RC, de Kort FAS, Stam M, Otto LAM, Asselman FL, Bartels B, van Eijk RPA, Sombroek J, Cuppen I, Verhoef M, van den Berg LH, Wadman RI, Castelein RM, van der Pol WL.
Año publicación:
2019
Número de revista:
Neurology vol. 93 n. 2
http://n.neurology.org/content/93/2/e149.abstract
Artículo
Epilepsy duration and seizure outcome in epilepsy surgery: A systematic review and meta-analysis
Autor/es:
Bjellvi J, Olsson I, Malmgren K, Wilbe Ramsay K.
Año publicación:
2019
Número de revista:
Neurology vol. 93 n. 2
http://n.neurology.org/content/93/2/e159.abstract
Artículo
Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs
Blotière PO, Raguideau F, Weill A, Elefant E, Perthus I, Goulet V, Rouget F, Zureik M, Coste J, Dray-Spira R.
Año publicación:
2019
Número de revista:
Neurology vol. 93 n. 2
http://n.neurology.org/content/93/2/e167.abstract
Artículo
Epidemiology of NMOSD in Sweden from 1987 to 2013: A nationwide population-based study
Autor/es:
Jonsson DI, Sveinsson O, Hakim R, Brundin L
Año publicación:
2019
Número de revista:
Neurology vol. 93 n. 2
http://n.neurology.org/content/93/2/e181.abstract
Artículo
Cognitive function in individuals with chronic DAI is not improved by high-frequency rTMS over the left DLPFC, though it appears safe and well-tolerated in this population.
Autor/es:
Neville IS, Zaninotto AL, Hayashi CY, Rodrigues PA, Galhardoni R, Ciampi de Andrade D, Brunoni AR, Amorim RLO, Teixeira MJ, Paiva WS.
Null Hypothesis
Año publicación:
2019
Número de revista:
Neurology vol. 93 n. 2
http://n.neurology.org/content/93/2/e190.abstract
Artículo
A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex
Autor/es:
Overwater IE, Rietman AB, Mous SE, Bindels-de Heus K, Rizopoulos D, Ten Hoopen LW, van der Vaart T, Jansen FE, Elgersma Y, Moll HA, de Wit MY; ENCORE Expertise Centre for Neurodevelopmental Disorders.
Null Hypothesis
Año publicación:
2019
Número de revista:
Neurology vol. 93 n. 2
http://n.neurology.org/content/93/2/e200.abstract
Artículo
ALS drug development guidances and trial guidelines: Consensus and opportunities for alignment
Autor/es:
Andrews JA, Bruijn LI, Shefner JM.
Views & Reviews
Año publicación:
2019
Número de revista:
Neurology vol. 93 n. 2
http://n.neurology.org/content/93/2/66.abstract
Artículo
Subthreshold amyloid and its biological and clinical meaning: Long way ahead
Autor/es:
Bischof GN, Jacobs HIL
Views & Reviews
Año publicación:
2019
Número de revista:
Neurology vol. 93 n. 2
http://n.neurology.org/content/93/2/72.abstract

Una iniciativa de:

Buscador

Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease

Neuropathy with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A meta-analysis

Natural course of scoliosis and lifetime risk of scoliosis surgery in spinal muscular atrophy

Epilepsy duration and seizure outcome in epilepsy surgery: A systematic review and meta-analysis

Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs

Epidemiology of NMOSD in Sweden from 1987 to 2013: A nationwide population-based study

Cognitive function in individuals with chronic DAI is not improved by high-frequency rTMS over the left DLPFC, though it appears safe and well-tolerated in this population.

A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex

ALS drug development guidances and trial guidelines: Consensus and opportunities for alignment

Subthreshold amyloid and its biological and clinical meaning: Long way ahead

¿Crees que falta información? ¡Haznos llegar tus sugerencias!